tryptanthrine has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, IJ; Jung, DH; Jung, EH; Jung, JY; Kim, JK; Kim, SC; Kim, YW; Ko, HL; Ku, SK; Park, CA; Park, SM | 1 |
| Cheng, W; Hou, BL; Liang, YN; Wang, T; Wang, Z; Zhu, J | 1 |
2 other study(ies) available for tryptanthrine and arachidonic acid
| Article | Year |
|---|---|
Tryptanthrin prevents oxidative stress-mediated apoptosis through AMP-activated protein kinase-dependent p38 mitogen-activated protein kinase activation.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Arachidonic Acid; Dose-Response Relationship, Drug; Glutathione; Hep G2 Cells; Humans; Iron; Male; Mice; Mice, Inbred ICR; Mitochondria; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protective Agents; Quinazolines; Reactive Oxygen Species | 2017 |
[Mechanism of tryptanthrin in treatment of ulcerative colitis in mice based on serum metabolomics].
Topics: Animals; Arachidonic Acid; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Interleukin-6; Metabolomics; Mice; Mice, Inbred C57BL; Purines; Tryptophan; Tumor Necrosis Factor-alpha | 2023 |